Aryl hydrocarbon receptor knockout accelerates PanIN formation and fibro-inflammation in a mutant Kras-driven pancreatic cancer model

OBJECTIVES: The pathogenesis of pancreas cancer (PDAC) remains poorly understood, hindering efforts to develop a more effective therapy for PDAC. Recent discoveries show the aryl hydrocarbon receptor (AHR) plays a crucial role in the pathogenesis of several cancers, and can be targeted for therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Walcheck, Morgan T., Schwartz, Patrick B., Carrillo, Noah D., Matkowsky, Kristina A., Nukaya, Manabu, Bradfield, Christopher A., Ronnekleiv-Kelly, Sean M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915668/
https://www.ncbi.nlm.nih.gov/pubmed/36778364
http://dx.doi.org/10.1101/2023.02.01.526625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915668/
https://www.ncbi.nlm.nih.gov/pubmed/36778364
http://dx.doi.org/10.1101/2023.02.01.526625

Ejemplares similares